Skip to main content
. 2022 Jun 9;4(4):e1409–e1415. doi: 10.1016/j.asmr.2022.04.030

Table 3.

Patient-Reported Outcomes

Follow-Up in Years, Median (IQR) 3.7 (1.0-5.8)
IKDC score 70.2 (50.6-90)
VAS pain, at rest 0 (0-2)
VAS pain, with use 1.8 (0-5.3)
Tegner 4 (3.8-6.3)
Extension
 Maintained 17 (94%)
 Worsened 1 (6%)

Presented as median interquartile range (IQR), n (%) unless otherwise stated.